The Pathophysiology of Orthostatic Hypotension
2 other identifiers
interventional
10
1 country
1
Brief Summary
The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Dec 1996
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1996
CompletedFirst Submitted
Initial submission to the registry
September 5, 2008
CompletedFirst Posted
Study publicly available on registry
September 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedMay 12, 2021
May 1, 2021
24 years
September 5, 2008
May 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hemodynamic changes with standing
following test
Secondary Outcomes (9)
blood and urine hormones
after test
blood volume
during supine and/or upright postures
sympathetic nerve activity
during stimulation of sympathetic nervous system
quantitative sweat testing
2 hours
Eye function
once
- +4 more secondary outcomes
Study Arms (1)
A
EXPERIMENTALPatients with Orthostatic Hypotension
Interventions
Blood pressure receptors in the neck arteries may be stimulated by applying suction through a collar around the neck.
IV Pharmacological Testing phenylephrine 12.5 - 400 ug, isoproterenol 0.1 - 0.4 ug or higher until desired effect, nitroprusside 0.1 - 1.6 ug/kg, propranolol 1.1 mg/min, edrophonium maximum of 10 mg, atropine .01 mg/kg, tyramine 250-4000 ug or higher until desired effect
Oral Pharmacological Testing clonidine 0.1-0.3 mg, yohimbine 5-10 mg, metoclopramide 10 mg, alpha-methyldopa 62.5 mg, placebo
Examination of pressure in the eye and eyelid fatiguability. The following eyedrops might be used: 1. 0.5% proparacaine (Alcaine, Allergan, Inc) 2. Fluress (0.4% benoxinate hydrochloride, fluorescein sodium, Akorn, Inc) 3. 0.5%, 1% tropicamide (Mydriacyl, Alcon) 4. Over-the-counter preservative-free artificial tears 5. 0.25%, 2.5% and 10% phenylephrine (Bausch and Lomb) 6. 1% cyclopentolate hydrochloride (Alcon)
Determination of metabolic rate via 24hr stay in whole-room indirect calorimeter
Questionnaires and computer tasks, an EEG and an MRI may be used to assess brain function.
Blood pressure and heart rate may be monitored while exercising on a stationary bicycle.
Eligibility Criteria
You may qualify if:
- severe orthostatic hypotension and other autonomic symptoms but do not meet criteria for standard diagnosis
- non-smokers
- drug-free
- able to give informed consent
- free of pulmonary, renal, hematopoietic, hepatic and cardiac disease
You may not qualify if:
- medications affecting the autonomic nervous system
- any chronic illness
- anemia (Hct\<30)
- women of childbearing age who are pregnant or nursing
- smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University
Nashville, Tennessee, 37232, United States
Related Publications (1)
Arnold AC, Garland EM, Celedonio JE, Raj SR, Abumrad NN, Biaggioni I, Robertson D, Luther JM, Shibao CA. Hyperinsulinemia and Insulin Resistance in Dopamine beta-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2017 Jan 1;102(1):10-14. doi: 10.1210/jc.2016-3274.
PMID: 27778639DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily M Garland, PhD
Vanderbilt University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
September 5, 2008
First Posted
September 8, 2008
Study Start
December 1, 1996
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
May 12, 2021
Record last verified: 2021-05